We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Glaxo to develop TCM
Pharmaceutical giant GlaxoSmithKline is poised to begin developing products based on traditional Chinese medicines as part of its revamped research and development strategy.
Already subscribed?
Not yet subscribed?
Subscribe to the Journal of Chinese Medicine now from only £30.00 per year. Your subscription will include:
- Access to the Research Archive
- Access to the Article Archive
- Three printed issues per year